Heparan Sulfate Biosynthesis: Methods for Investigation of the Heparanosome

per Multhaupt, Hinke A. B., Couchman, John R.
Publicat 2012

The Rho kinases I and II regulate different aspects of myosin II activity

per Yoneda, Atsuko, Multhaupt, Hinke A.B., Couchman, John R.
Publicat 2005

Protein Kinase C, Focal Adhesions and the Regulation of Cell Migration

per Fogh, Betina S., Multhaupt, Hinke A.B., Couchman, John R.
Publicat 2014

Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -II

per Yoneda, Atsuko, Ushakov, Dmitriy, Multhaupt, Hinke A.B., Couchman, John R.
Publicat 2007

Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans

per Yoneda, Atsuko, Lendorf, Maria E., Couchman, John R., Multhaupt, Hinke A. B.
Publicat 2012

Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma

per Lendorf, Maria E., Manon-Jensen, Tina, Kronqvist, Pauliina, Multhaupt, Hinke A. B., Couchman, John R.
Publicat 2011

Heparan Sulfate Chain Valency Controls Syndecan-4 Function in Cell Adhesion

per Gopal, Sandeep, Bober, Adam, Whiteford, James R., Multhaupt, Hinke A. B., Yoneda, Atsuko, Couchman, John R.
Publicat 2010

IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules

per Afratis, Nikolaos A., Bouris, Panagiotis, Skandalis, Spyros S., Multhaupt, Hinke A., Couchman, John R., Theocharis, Achilleas D., Karamanos, Nikos K.
Publicat a Sci Rep (2017)

Serine 34 Phosphorylation of Rho Guanine Dissociation Inhibitor (RhoGDIα) Links Signaling from Conventional Protein Kinase C to RhoGTPase in Cell Adhesion

per Dovas, Athanassios, Choi, Youngsil, Yoneda, Atsuko, Multhaupt, Hinke A. B., Kwon, Seung-Hae, Kang, Dongmin, Oh, Eok-Soo, Couchman, John R.
Publicat 2010

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

per Kullmann, F, Hollerbach, S, Dollinger, M M, Harder, J, Fuchs, M, Messmann, H, Trojan, J, Gäbele, E, Hinke, A, Hollerbach, C, Endlicher, E
Publicat 2009

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

per Hoehler, T, von Wichert, G, Schimanski, C, Kanzler, S, Moehler, M H, Hinke, A, Seufferlein, T, Siebler, J, Hochhaus, A, Arnold, D, Hallek, M, Hofheinz, R, Hacker, U T
Publicat 2013

Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil i...

per Wilkowski, R, Boeck, S, Ostermaier, S, Sauer, R, Herbst, M, Fietkau, R, Flentje, M, Miethe, S, Boettcher, H D, Scholten, T, Bruns, C J, Rau, H G, Hinke, A, Heinemann, V
Publicat 2009

Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels

per Gopal, Sandeep, Søgaard, Pernille, Multhaupt, Hinke A.B., Pataki, Csilla, Okina, Elena, Xian, Xiaojie, Pedersen, Mikael E., Stevens, Troy, Griesbeck, Oliver, Park, Pyong Woo, Pocock, Roger, Couchman, John R.
Publicat a J Cell Biol (2015)

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine

per Theocharis, Achilleas D., Skandalis, Spyros S., Neill, Thomas, Multhaupt, Hinke A. B., Hubo, Mario, Frey, Helena, Gopal, Sandeep, Gomes, Angélica, Afratis, Nikos, Lim, Hooi Ching, Couchman, John R., Filmus, Jorge, Sanderson, Ralph D., Schaefer, Liliana, Iozzo, Renato V., Karamanos, Nikos K.
Publicat a Biochim Biophys Acta (2015)